|
7/14/2009 - Tracy Lawhon, J.D. of Tragara Pharmaceuticals, Inc., will be a keynote speaker at the Sixth BVS La Jolla Biotech Event on July 22, 2009.
4/14/2009 - Apricoxib Phase I Study Results to be Presented at AACR in Denver, CO.
3/27/2009 - Tragara Pharmaceuticals Chief Executive Officer, Thomas M. Estok, to speak at Defined Health's annual pharma conference, Therapeutic Insight, taking place in New York City March 31st through April 2nd, 2009.
2/18/2009 - Christopher C. LeMasters, MBA, Chief Business Officer for Tragara Pharmaceuticals, to speak at Connect?Frameworks Workshops Drug Development in a Capital Constrained Economy, February 19, 2009
1/21/2009 - S*BIO and Tragara Announce an Exclusive Worldwide License Agreement for Novel Multi-kinase Inhibitor SB1317
5/8/2008 - Sara Zaknoen, Chief Medical Officer for Tragara Pharmaceuticals, to speak at UCSD Moores Cancer Center in San Diego, CA
4/2/2008 - Tragara Pharmaceuticals Chief Executive Officer, Thomas M. Estok, to speak at 2008 BIO-Europe Spring Conference in Madrid, Spain
3/13/2008 - Tracy Lawhon, J.D. of Tragara Pharmaceuticals, Inc., will be a keynote speaker and a participant in a panel discussion at Indiana University on April 2-3, 2008
1/28/2008 - Tragara Pharmaceuticals’ Chief Business Officer, Christopher C. LeMasters, to speak at 2008 BIO Asia Conference in Tokyo, Japan
3/13/2007 - Tragara
Raises $40 million Series A Financing
|